Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)

Market Cap	33.27B -40.3%
Revenue (ttm)	8.75B -48.5%
Net Income	-14.78B
EPS	-6.18
Shares Out	2.39B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	112,227,299
Open	13.10
Previous Close	14.48
Day's Range	13.10 - 14.46
52-Week Range	11.07 - 24.37
Beta	0.45
Analysts	Buy
Price Target	21.17 (+52.3%)
Earnings Date	Aug 29, 2026

About SHE:300122

Chongqing Zhifei Biological Products Co., Ltd., a biopharmaceutical company, engages in the research and development, production, sale, and distribution of vaccine and biological products in China. The company offers recombinant COVID-19 vaccine; recombinant mycobacterium tuberculosis fusion protein products; group A and C meningococcal polysaccharide vaccine; ACYW135 meningococcal polysaccharide vaccine; Haemophilus Influenza type B conjugate vaccine; mycobacterium injection under the Vaccae brand; and meningococcal group A and C conjugate vac...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 6,292
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300122

Analyst Summary

According to 3 analysts, the average rating for 300122 stock is "Buy." The 12-month stock price target is ¥21.17, which is an increase of 52.30% from the latest price.

Price Target

¥21.17

(52.30% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 21, 2026

Data Sources Report a data error